Clinical Trials on Neoplasms, Multiple Primary in United Kingdom
Total 65959 results
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Royal Surrey County Hospital NHS Foundation TrustUniversity of Surrey; Target Ovarian CancerUnknownPeritoneal Diseases | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Abdominal Neoplasm | Bowel Obstruction | Primary Peritoneal Carcinoma | Metastatic Ovarian Cancer | Ovarian DiseaseUnited Kingdom
-
Swansea UniversityAbertawe Bro Morgannwg University Health BoardCompletedBladder CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; National Institute for...Completed
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai PharmaceuticalRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Solid TumoursUnited Kingdom
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingGenetic Mutation | MEN1United States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingMultiple MyelomaUnited Kingdom
-
The Christie NHS Foundation TrustAstraZenecaUnknown
-
University College, LondonCompletedMultiple Sclerosis | Overactive BladderUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
Oxford University Hospitals NHS TrustActive, not recruitingPneumoperitoneum | Pneumothorax | Cardiomegaly | Pleural Effusion | Atelectasis | Pulmonary Nodules, Solitary | Pneumothorax; Acute | Pleural Effusions, Chronic | Pulmonary Nodules, Multiple | Fibrosis Lung | Pulmonary Consolidation | Pulmonary CalcificationUnited Kingdom
-
Jersey Shore University Medical CenterRutgers University; Rutgers Cancer Institute of New JerseyCompletedPancreatic Cancer | Parathyroid Disease | Thymic Cancer | MEN1 SyndromeUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United Kingdom; National...RecruitingInvasive Bladder CancerUnited Kingdom
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
The Royal Wolverhampton Hospitals NHS TrustUniversity of WolverhamptonRecruiting
-
Royal Marsden NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedBone Metastases | Brain Metastases | Brain Tumor, Primary | Brain Tumor Adult | Brain Tumor - MetastaticUnited Kingdom
-
University Hospitals Bristol and Weston NHS Foundation...SanofiCompletedPenile NeoplasmUnited Kingdom
-
The Christie NHS Foundation TrustCellCentric Ltd.Not yet recruitingMultiple MyelomaUnited Kingdom
-
Royal National Orthopaedic Hospital NHS TrustTerminatedMultiple MyelomaUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Royal Marsden NHS Foundation TrustCompleted
-
National Cancer Institute (NCI)CompletedPancreatic Neuroendocrine Carcinoma | Multiple Endocrine Neoplasia Type 1United States
-
Trio Medicines Ltd.BiogenCompleted
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
University of GlasgowCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of LiverpoolGenzyme, a Sanofi CompanyUnknownLymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell DyscrasiaUnited Kingdom
-
East and North Hertfordshire NHS TrustKDx Diagnostics Inc.Recruiting
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknown
-
ViralyticsCompletedNon-muscle Invasive Bladder CancerUnited Kingdom
-
Medical Research CouncilCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Prof Jamie CavenaghNovartis; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
University of South FloridaBoston Children's HospitalCompletedPTEN Gene MutationUnited States
-
University of BirminghamUnknownBladder CancerUnited Kingdom
-
University Hospital BirminghamUnknownBladder CancerUnited Kingdom
-
Medical Research CouncilCompletedBladder CancerUnited Kingdom
-
University College, LondonEnrolling by invitationMultiple MyelomaUnited Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CopenhagenActive, not recruiting
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom